486 related articles for article (PubMed ID: 16741579)
1. Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance.
Gutiérrez-Juárez R; Pocai A; Mulas C; Ono H; Bhanot S; Monia BP; Rossetti L
J Clin Invest; 2006 Jun; 116(6):1686-95. PubMed ID: 16741579
[TBL] [Abstract][Full Text] [Related]
2. Probing the role of stearoyl-CoA desaturase-1 in hepatic insulin resistance.
Flowers MT; Miyazaki M; Liu X; Ntambi JM
J Clin Invest; 2006 Jun; 116(6):1478-81. PubMed ID: 16741573
[TBL] [Abstract][Full Text] [Related]
3. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
4. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet.
Kuda O; Stankova B; Tvrzicka E; Hensler M; Jelenik T; Rossmeisl M; Flachs P; Kopecky J
J Physiol Pharmacol; 2009 Dec; 60(4):135-40. PubMed ID: 20065507
[TBL] [Abstract][Full Text] [Related]
5. Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis.
Miyazaki M; Flowers MT; Sampath H; Chu K; Otzelberger C; Liu X; Ntambi JM
Cell Metab; 2007 Dec; 6(6):484-96. PubMed ID: 18054317
[TBL] [Abstract][Full Text] [Related]
6. Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro.
Pinnamaneni SK; Southgate RJ; Febbraio MA; Watt MJ
Diabetologia; 2006 Dec; 49(12):3027-37. PubMed ID: 17033839
[TBL] [Abstract][Full Text] [Related]
7. Stearoyl-CoA desaturase and insulin signaling--what is the molecular switch?
Dobrzyn P; Jazurek M; Dobrzyn A
Biochim Biophys Acta; 2010; 1797(6-7):1189-94. PubMed ID: 20153289
[TBL] [Abstract][Full Text] [Related]
8. Stearoyl-CoA Desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice.
Yokoyama S; Hosoi T; Ozawa K
Gene; 2012 Apr; 497(2):340-3. PubMed ID: 22326531
[TBL] [Abstract][Full Text] [Related]
9. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1.
Jiang G; Li Z; Liu F; Ellsworth K; Dallas-Yang Q; Wu M; Ronan J; Esau C; Murphy C; Szalkowski D; Bergeron R; Doebber T; Zhang BB
J Clin Invest; 2005 Apr; 115(4):1030-8. PubMed ID: 15761499
[TBL] [Abstract][Full Text] [Related]
10. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: implications for a role of stearoyl-CoA desaturase 1 in insulin resistance.
Voss MD; Beha A; Tennagels N; Tschank G; Herling AW; Quint M; Gerl M; Metz-Weidmann C; Haun G; Korn M
Diabetologia; 2005 Dec; 48(12):2622-30. PubMed ID: 16284748
[TBL] [Abstract][Full Text] [Related]
12. Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase.
Liu J; Cinar R; Xiong K; Godlewski G; Jourdan T; Lin Y; Ntambi JM; Kunos G
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18832-7. PubMed ID: 24191036
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models.
Issandou M; Bouillot A; Brusq JM; Forest MC; Grillot D; Guillard R; Martin S; Michiels C; Sulpice T; Daugan A
Eur J Pharmacol; 2009 Sep; 618(1-3):28-36. PubMed ID: 19616540
[TBL] [Abstract][Full Text] [Related]
14. Diet-dependent alterations of hepatic Scd1 expression are accompanied by differences in promoter methylation.
Schwenk RW; Jonas W; Ernst SB; Kammel A; Jähnert M; Schürmann A
Horm Metab Res; 2013 Oct; 45(11):786-94. PubMed ID: 23803969
[TBL] [Abstract][Full Text] [Related]
15. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
Dobrzyń A; Dobrzyń P
J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis.
Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen T; Zhu X; Duong MN; Wibley AL; Shah R; Davis MA; Kelley K; Wilson MD; Kent C; Parks JS; Rudel LL
Circulation; 2008 Sep; 118(14):1467-75. PubMed ID: 18794388
[TBL] [Abstract][Full Text] [Related]
17. Stearoyl-CoA desaturase-1 (SCD1) augments saturated fatty acid-induced lipid accumulation and inhibits apoptosis in cardiac myocytes.
Matsui H; Yokoyama T; Sekiguchi K; Iijima D; Sunaga H; Maniwa M; Ueno M; Iso T; Arai M; Kurabayashi M
PLoS One; 2012; 7(3):e33283. PubMed ID: 22413010
[TBL] [Abstract][Full Text] [Related]
18. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
[TBL] [Abstract][Full Text] [Related]
19. Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice.
Hu CC; Qing K; Chen Y
Obes Res; 2004 Aug; 12(8):1264-70. PubMed ID: 15340109
[TBL] [Abstract][Full Text] [Related]
20. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
